Overview

Covalon Technologies Ltd. is a researcher, developer, manufacturer, and marketer of patent-protected medical products that improve patient outcomes and save lives in the areas of advanced wound care, infection management and surgical procedures. Our head office and laboratories are located in Mississauga, Ontario, Canada. Covalon leverages its patented medical technology platforms and expertise in two ways: (i) we develop products that we sell under Covalon’s name; and, (ii) we develop and commercialize medical products for other medical companies under development and license contracts.  The Company is listed on the TSX Venture Exchange, having the symbol COV and trades on the OTQX Market under the symbol CVALF.  Covalon is incorporated under the laws of Ontario.

Stock Info
TSXVCOV
Press Releases
May 30, 2022

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced its second quarter fiscal 2022 results. Brian Pedlar,...

May 26, 2022

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTC: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2022 financial results on Monday May 30th,...

May 25, 2022

Covalon Technologies Ltd. (TSXV: COV) (OTCQX: CVALF) (the "Company" or "Covalon"), an advanced medical technologies company, today announced that it has filed its intention to make a normal course...

View All

Email Alerts
* Required Fields
Events
Monday, May 30, 2022
9:00am - 10:00am EDT
Wednesday, March 9, 2022
3:30pm EST
Tuesday, March 1, 2022
9:00am EST

View All

Contact Us

For investor relations inquiries, please contact Brian Pedlar (CEO).
e-mail: bpedlar@covalon.com

To contact the Board of Directors to provide comments, report concerns, or ask a question, please contact Amir Boloor (Chair of the Board).
e-mail: aboloor@covalon.com

 

Contact Form